Synthetic lethality of KDM1A and mTOR inhibitors: A novel combination therapy for endometrial cancer

被引：0

作者：

Pitta-Venkata, Prabhakar ^{[1
]}

Palacios, Bridgitte ^{[1
]}

Chen, Yihong ^{[1
]}

Viswanadhapalli, Suryavathi ^{[1
]}

Pratap, Uday P. ^{[1
]}

Luo, Yiliao ^{[1
]}

Li, Mengxing ^{[1
]}

Altwegg, Kristin ^{[1
]}

Li, Xiaonan ^{[1
]}

Suzuki, Takayoshi ^{[2
]}

Tekmal, Rajeshwar Rao ^{[1
]}

Kost, Edward ^{[1
]}

Sareddy, Gangadhara Reddy ^{[1
]}

机构：

[1] UT Hlth San Antonio, San Antonio, TX USA

[2] Kyoto Prefectural Univ Med, Kyoto, Japan

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2019-280

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

280

引用

页数：2

共 50 条

[31] Exploiting synthetic lethality to improve cancer therapy [J].

Diede Brunen ;

René Bernards .

Nature Reviews Clinical Oncology, 2017, 14 :331-332

[32] KDM1A/ LSD1 inhibition enhances chemotherapy response in ovarian cancer [J].

Johnson, Jessica D. ;

Chen, Yihong ;

Jayamohan, Sridharan ;

He, Yi ;

Jamwal, Diksha ;

Pandey, Neetesh ;

Kost, Edward ;

Vadlamudi, Ratna K. ;

Sareddy, Gangadhara R. .

CANCER RESEARCH, 2024, 84 (06)

[33] Epigenetic synthetic lethality approaches in cancer therapy [J].

Yang, Haoshen ;

Cui, Wei ;

Wang, Lihui .

CLINICAL EPIGENETICS, 2019, 11 (01)

[34] Exploiting synthetic lethality to improve cancer therapy [J].

Brunen, Diede ;

Bernards, Rene .

NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (06) :331-332

[35] Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells [J].

Kim, Hyera ;

Lee, Su Jin ;

Lee, In Kyoung ;

Min, Suejean C. ;

Sung, Hyun Hwan ;

Jeong, Byong Chang ;

Lee, Jeeyun ;

Park, Se Hoon .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)

[36] Epigenetic synthetic lethality approaches in cancer therapy [J].

Haoshen Yang ;

Wei Cui ;

Lihui Wang .

Clinical Epigenetics, 2019, 11

[37] SYNTHETIC LETHALITY SCREENING FOR THE DEVELOPMENT OF RATIONAL COMBINATION THERAPY FOR LEUKEMIA [J].

Porter, C. ;

Fosmire, P. ;

Tan, A. C. ;

Gregory, M. ;

Degregori, V. .

ANNALS OF ONCOLOGY, 2012, 23 :21-21

[38] Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021 [J].

Song, Yihui ;

Zhang, Huiqing ;

Yang, Xiaoke ;

Shi, Yuting ;

Yu, Bin .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 228

[39] Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A) [J].

Borrello, Maria Teresa ;

Schinor, Benjamin ;

Bartels, Katharina ;

Benelkebir, Hanae ;

Pereira, Sara ;

Al-Jamal, Wafa T. ;

Douglas, Leon ;

Duriez, Patrick J. ;

Packham, Graham ;

Haufe, Guenter ;

Ganesan, A. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (10) :2099-2101

[40] mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy [J].

Baldo, Paolo ;

Cecco, Sara ;

Giacomin, Elisa ;

Lazzarini, Renzo ;

Rose, Barbara ;

Marastoni, Stefano .

CURRENT CANCER DRUG TARGETS, 2008, 8 (08) :647-665

← 1 2 3 4 5 →